This compound, methyl 6-(4-hydroxybut-1-yn-1-yl)nicotinate, is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological disorders. Its structure, featuring a methyl nicotinate core substituted at the 6-position with a 4-hydroxybut-1-yn-1-yl group, allows for further functionalization, making it valuable in the creation of compounds with potential therapeutic effects. Additionally, it is explored in the development of novel drugs that modulate specific receptors or enzymes in the body. Its application extends to organic synthesis, where it is used to build complex molecular frameworks for further chemical studies.